MedPage Today on MSN
PSMA-PET cuts need for biopsy in suspected prostate cancer
But does it cost too much?
It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.
The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...
"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results